Cambridge Nutritional Sciences PLC
LSE:CNSL

Watchlist Manager
Cambridge Nutritional Sciences PLC Logo
Cambridge Nutritional Sciences PLC
LSE:CNSL
Watchlist
Price: 2 GBX 5.26%
Market Cap: £4.8m

Relative Value

The Relative Value of one CNSL stock under the Base Case scenario is hidden GBX. Compared to the current market price of 2 GBX, Cambridge Nutritional Sciences PLC is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CNSL Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

CNSL Competitors Multiples
Cambridge Nutritional Sciences PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Cambridge Nutritional Sciences PLC
LSE:CNSL
4.8m GBP 0.6 3.5 13.6 -2.3
US
Medline Inc
NASDAQ:MDLN
58.5B USD 0 0 0 0
JP
Hoya Corp
TSE:7741
9.3T JPY 10.4 44.2 27.6 33
CH
Alcon AG
SIX:ALC
30.6B CHF 3.8 37.1 19.4 37.8
DK
Coloplast A/S
CSE:COLO B
118.9B DKK 4.3 32.7 15.1 18
US
Align Technology Inc
NASDAQ:ALGN
11.8B USD 3 31.1 14.1 17.9
UK
ConvaTec Group PLC
LSE:CTEC
4.8B GBP 2.7 29.3 17.7 28.7
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.6B CNY 9.4 26 23.3 23.3
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD 1.2 -19.6 19.5 92
CH
Ypsomed Holding AG
SIX:YPSN
4.2B CHF 5.3 21.6 14 19
KR
HLB Inc
KOSDAQ:028300
7.1T KRW 81.6 -29.9 -74.9 -70.9
P/E Multiple
Earnings Growth PEG
UK
Cambridge Nutritional Sciences PLC
LSE:CNSL
Average P/E: 28.2
3.5
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
JP
Hoya Corp
TSE:7741
44.2
13%
3.4
CH
Alcon AG
SIX:ALC
37.1
25%
1.5
DK
Coloplast A/S
CSE:COLO B
32.7
22%
1.5
US
Align Technology Inc
NASDAQ:ALGN
31.1
27%
1.2
UK
ConvaTec Group PLC
LSE:CTEC
29.3
33%
0.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
26
9%
2.9
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -19.6 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
21.6
32%
0.7
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -29.9 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
Cambridge Nutritional Sciences PLC
LSE:CNSL
Average EV/EBITDA: 18.3
13.6
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
JP
Hoya Corp
TSE:7741
27.6
11%
2.5
CH
Alcon AG
SIX:ALC
19.4
8%
2.4
DK
Coloplast A/S
CSE:COLO B
15.1
8%
1.9
US
Align Technology Inc
NASDAQ:ALGN
14.1
13%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
17.7
10%
1.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.3
15%
1.6
CA
Bausch + Lomb Corp
NYSE:BLCO
19.5
21%
0.9
CH
Ypsomed Holding AG
SIX:YPSN
14
21%
0.7
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -74.9 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
Cambridge Nutritional Sciences PLC
LSE:CNSL
Average EV/EBIT: 33.7
Negative Multiple: -2.3
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
JP
Hoya Corp
TSE:7741
33
N/A N/A
CH
Alcon AG
SIX:ALC
37.8
23%
1.6
DK
Coloplast A/S
CSE:COLO B
18
8%
2.2
US
Align Technology Inc
NASDAQ:ALGN
17.9
16%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
28.7
22%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.3
11%
2.1
CA
Bausch + Lomb Corp
NYSE:BLCO
92
60%
1.5
CH
Ypsomed Holding AG
SIX:YPSN
19
29%
0.7
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -70.9 N/A N/A